In Part II of this series, I described the notion of demoralization among individuals receiving chemotherapy. When individuals are demoralized, they are experiencing many symptoms that are shared by clinical depression, e.g. fatigue, loss of interest, decreased appetite, loss of motivation, difficulties with concentration, and feelings of worthlessness. In fact, the picture may look so much like depression that these individuals may be placed on antidepressant medication and referred for...
Read moreI started writing about depression 25 years ago, a different kind of depression.In 1983, one year out of law school, I began what I thought... Read more »
To say that getting through the holidays with depression is difficult is like saying that travel goes up slightly during the holidays. The... Read more »
We've probably all come across them at some point. The little boy or girl who doesn't seem to interact well or enjoy the games others are... Read more »
Over the years, I've learned a few things about depression that would have surprised me when I first started having symptoms. More... Read more »
If you had unlimited finances, access to every possible pharmacologic compound-including experimental ones in clinical trials, or even... Read more »
In Part 1 of this piece, I very briefly described emotional states related to feelings of depression and depressed mood. I then, even more briefly,... Read more »
Labopharm, the manufacturer of the once-a-day antidepressant Trazodone, is enrolling patients in a national clinical trial. The once-a-day formula is... Read more »
This is a study to assess the safety and effectiveness of the drug lurasidone in people who have bipolar I depression. This national study is... Read more »
This is a study to assess the safety, tolerability, and effectiveness of Geodon (ziprasidone) as a stand-alone treatment for people with major... Read more »
This is a study to assess the safety and effectiveness of Valdoxan in patients with major depressive disorder. This national study is currently... Read more »